Susquehanna International Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $819K | Buy |
+2,938
| New | +$846K | ﹤0.01% | 8416 |
|
|
2025
Q4 | – | Sell |
-1,611
| Closed | -$503K | – | 12367 |
|
|
2025
Q3 | $452K | Sell |
1,611
-5,750
| -78% | -$1.56M | ﹤0.01% | 9194 |
|
|
2025
Q2 | $1.78M | Sell |
7,361
-3,805
| -34% | -$899K | ﹤0.01% | 6051 |
|
|
2025
Q1 | $2.72M | Buy |
11,166
+7,411
| +197% | +$2.23M | ﹤0.01% | 4861 |
|
|
2024
Q4 | $1.23M | Sell |
3,755
-27,910
| -88% | -$9.47M | ﹤0.01% | 6450 |
|
|
2024
Q3 | $10.6M | Buy |
31,665
+20,304
| +179% | +$6.45M | ﹤0.01% | 2542 |
|
|
2024
Q2 | $3.1M | Sell |
11,361
-509
| -4% | -$148K | ﹤0.01% | 4248 |
|
|
2024
Q1 | $4.11M | Buy |
11,870
+5,709
| +93% | +$1.88M | ﹤0.01% | 3971 |
|
|
2023
Q4 | $1.99M | Sell |
6,161
-17,777
| -74% | -$5.57M | ﹤0.01% | 5359 |
|
|
2023
Q3 | $8.58M | Buy |
23,938
+13,911
| +139% | +$5.37M | ﹤0.01% | 2757 |
|
|
2023
Q2 | $3.8M | Sell |
10,027
-2,597
| -21% | -$1.06M | ﹤0.01% | 3976 |
|
|
2023
Q1 | $6.05M | Buy |
12,624
+3,427
| +37% | +$1.6M | ﹤0.01% | 3162 |
|
|
2022
Q4 | $3.87M | Buy |
9,197
+7,734
| +529% | +$3.12M | ﹤0.01% | 3624 |
|
|
2022
Q3 | $610K | Sell |
1,463
-1,346
| -48% | -$671K | ﹤0.01% | 7948 |
|
|
2022
Q2 | $1.39M | Sell |
2,809
-5,147
| -65% | -$2.68M | ﹤0.01% | 5729 |
|
|
2022
Q1 | $4.48M | Buy |
7,956
+1,751
| +28% | +$1.06M | ﹤0.01% | 3822 |
|
|
2021
Q4 | $4.69M | Sell |
6,205
-1,550
| -20% | -$1.16M | ﹤0.01% | 3853 |
|
|
2021
Q3 | $5.79M | Buy |
7,755
+1,089
| +16% | +$816K | ﹤0.01% | 3695 |
|
|
2021
Q2 | $4.29M | Buy |
6,666
+3,091
| +86% | +$1.88M | ﹤0.01% | 4308 |
|
|
2021
Q1 | $2.04M | Sell |
3,575
-4,244
| -54% | -$2.51M | ﹤0.01% | 5862 |
|
|
2020
Q4 | $4.56M | Buy |
+7,819
| New | +$4.45M | ﹤0.01% | 3563 |
|
|
2020
Q3 | – | Sell |
-3,895
| Closed | -$1.97M | – | 10537 |
|
|
2020
Q2 | $1.76M | Sell |
3,895
-8,111
| -68% | -$3.58M | ﹤0.01% | 4734 |
|
|
2020
Q1 | $4.21M | Sell |
12,006
-3,151
| -21% | -$1.16M | ﹤0.01% | 2800 |
|
|
2019
Q4 | $5.61M | Buy |
15,157
+13,566
| +853% | +$4.78M | ﹤0.01% | 2822 |
|
|
2019
Q3 | $529K | Sell |
1,591
-52,611
| -97% | -$17.2M | ﹤0.01% | 7182 |
|
|
2019
Q2 | $16.9M | Buy |
+54,202
| New | +$16.2M | 0.01% | 1410 |
|
|
2018
Q4 | – | Sell |
-3,421
| Closed | -$918K | – | 8934 |
|
|
2018
Q3 | $1.07M | Buy |
3,421
+1,765
| +107% | +$548K | ﹤0.01% | 5088 |
|
|
2018
Q2 | $478K | Buy |
+1,656
| New | +$457K | ﹤0.01% | 6880 |
|
|
2017
Q2 | – | Sell |
-12,289
| Closed | -$2.68M | – | 9190 |
|
|
2017
Q1 | $2.45M | Buy |
+12,289
| New | +$2.37M | ﹤0.01% | 3364 |
|
|
2016
Q1 | – | Sell |
-8,951
| Closed | -$1.18M | – | 8995 |
|
|
2015
Q4 | $1.24M | Sell |
8,951
-258
| -3% | -$35.8K | ﹤0.01% | 4994 |
|
|
2015
Q3 | $1.24M | Buy |
9,209
+1,709
| +23% | +$246K | ﹤0.01% | 5247 |
|
|
2015
Q2 | $1.13M | Sell |
7,500
-1,838
| -20% | -$263K | ﹤0.01% | 5947 |
|
|
2015
Q1 | $1.26M | Buy |
9,338
+2,565
| +38% | +$318K | ﹤0.01% | 5291 |
|
|
2014
Q4 | $817K | Buy |
+6,773
| New | +$780K | ﹤0.01% | 6257 |
|
|
2014
Q2 | – | Sell |
-3,003
| Closed | -$367K | – | 9737 |
|
|
2014
Q1 | $385K | Sell |
3,003
-4,997
| -62% | -$641K | ﹤0.01% | 7186 |
|
|
2013
Q4 | $989K | Sell |
8,000
-4,260
| -35% | -$519K | ﹤0.01% | 5532 |
|
|
2013
Q3 | $1.44M | Sell |
12,260
-4,440
| -27% | -$524K | ﹤0.01% | 4676 |
|
|
2013
Q2 | $1.87M | Buy |
+16,700
| New | +$1.96M | ﹤0.01% | 4012 |
|
Other funds holding BIO
VCM
VPM
AI
Susquehanna International Group's BIO Position: Q1 2026 in Review
Susquehanna International Group opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 2,938 shares worth $819K. The stake represents ﹤0.01% of the portfolio and ranks #8416 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in BIO as recently as Q3 2025.
Susquehanna International Group first reported a position in BIO in Q2 2013 and has held it in 38 quarters since. The position peaked at $16.9M in Q2 2019. 393 funds tracked by Wall St. Rank hold BIO as of Q1 2026.
- Susquehanna International Group held 2,938 shares of Bio-Rad Laboratories Class A worth $819K as of Q1 2026.
- Bio-Rad Laboratories Class A was a new Susquehanna International Group position in Q1 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8416 holding.
- Susquehanna International Group first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 38 quarters since.
- Susquehanna International Group's Bio-Rad Laboratories Class A position peaked at $16.9M in Q2 2019.
- 393 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.